Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
Bioorganic & Medicinal Chemistry Letters|January 16, 2009
Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferasesAntonello Mai, Dante Rotili, Domenico Tarantino, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2005
Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamatesAntonello Mai, Silvio Massa, Dante Rotili, et al.
Chemmedchem|September 1, 2006
6-alkylthio-4-[1-(2,6-difluorophenyl)alkyl]-1H-[1,3,5]triazin-2-ones (ADATs): novel regulators of cell differentiation and proliferationGianluca Sbardella, Sara Bartolini, Sabrina Castellano, et al.
The Journal of Biological Chemistry|February 28, 2025
Duplexed CeTEAM drug biosensors reveal determinants of PARP inhibitor selectivity in cellsMaria J Pires, Seher Alam, Alen Lovric, et al.
European Journal of Medicinal Chemistry|October 28, 2015
Enzyme kinetics and inhibition of histone acetyltransferase KAT8Hannah Wapenaar, Petra E van der Wouden, Matthew R Groves, et al.
The International Journal of Biochemistry & Cell Biology|May 8, 2007
Novel pyrrole-containing histone deacetylase inhibitors endowed with cytodifferentiation activityAntonello Mai, Sergio Valente, Dante Rotili, et al.
European Journal of Pharmacology|April 9, 2019
Comparison of the effects of synthetic and plant-derived mTOR regulators on healthy human ovarian cellsAlexander V Sirotkin, Erika Adamcova, Dante Rotili, et al.
European Journal of Medicinal Chemistry|July 12, 2025
1,2,4-Oxadiazoles in medicinal chemistry: trends of the last yearsAnastasia Cherkasova, Roberta Astolfi, Maxim Nawrozkij, et al.
Chemmedchem|May 10, 2008
Substrate-induced stable enzyme-inhibitor complex formation allows tight binding of novel 2-aminopyrimidin-4(3H)-ones to drug-resistant HIV-1 reverse transcriptase mutantsAlberta Samuele, Marcella Facchini, Dante Rotili, et al.
Expert Opinion on Therapeutic Patents|March 11, 2024
Successes and challenges in the development of BD1-selective BET inhibitors: a patent reviewMonica Viviano, Alessandra Cipriano, Emanuele Fabbrizi, et al.
Pageof 20